Eagle Health Investments LP Neurocrine Biosciences Inc Transaction History
Eagle Health Investments LP
- $407 Million
- Q4 2024
A detailed history of Eagle Health Investments LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Eagle Health Investments LP holds 155,000 shares of NBIX stock, worth $17.3 Million. This represents 5.2% of its overall portfolio holdings.
Number of Shares
155,000
Previous 128,600
20.53%
Holding current value
$17.3 Million
Previous $14.8 Million
42.9%
% of portfolio
5.2%
Previous 2.81%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.58 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.13 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$545 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$336 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$283 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...